ERDON

This brand name is authorized in Nigeria.

Active ingredients

The drug ERDON contains one active pharmaceutical ingredient (API):

1	Diclofenac UNII QTG126297Q - DICLOFENAC SODIUM
	Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
	Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7198	Eye drops	ERDON EYE DROPS SOL_DROPS 0.1% 5ML	63 RNW-PP-275942 ERDON EYE DROPS DICLOFENAC SODIUM BP 0.1%W/V Diclofenac Sodium BP 0.1%W/V, Polyvinyl Alcohol, Polyoxyl 35 Castor Oil, Polyethylene Glycol 400, Boric Acid, Thiomersal, Tromethamine, Sodium Hydroxide or Hydrochloric Acid, Water for Injection A4-7198 Drugs MUSCULO-SKELETAL SYSTEM Imported Products 5ML POM 1 8/10/2022 VITACARE PHARMACY LIMITED, NO. 33, ANYIKA STREET, AWADA, ONITSHA, ANAMBRA STATE 70284899 vitacarepharmltd@yahoo.com ARISTOPHARMA LTD, PLOT 14 - 22, ROAD 11 & 12, SHAMPUR - KADAMTALI INDUSTRIAL AREA, DHAKA - 1204, BANGLADESH, Bangladesh	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BC03	Diclofenac	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7198